MAST1 levels were higher in ovarian cancer patients with high GR activity compared to patients with low GR activity, which was determined by transcriptome signature of glucocorticoid regulated genes (Fig. 2h). The gene discussed is NR3C1; the disease is ovarian carcinoma.